May 29, 2018

Ceres Power Holdings plc Q&A: Weichai Partnership (LON:CWR)

Ceres Power Holdings plc (LON:CWR) Chief Executive Officer Phil Caldwell caught up with DirectorsTalk for an exclusive interview to discuss their partnership with Weichai Power, why they looked at China..

Nektan PLC Q&A with Interim CEO Gary Shaw (LON:NKTN)

Nektan PLC (LON:NKTN) Interim Chief Executive Officer Gary Shaw caught up with DirectorsTalk for an exclusive interview to discuss how things are progressing for the company, the significance of the..

INTERVIEW: Strix Group Plc Benefiting from a strong patent protection strategy

Strix Group Plc (LON:KETL) CEO Mark Bartlett talks to DirectorsTalk about its IP. With a portfolio now of over 150 patents, Mark tells us more about this and why it..

Allergy Therapeutics Plc Positive new clinical data with house-dust mite immunotherapy

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today announced positive new data on its wholly-owned modified house-dust mite subcutaneous immunotherapy1. This data will..

OnTheMarket plc 8,500+ agent branches with 3,000+ branches contracted since Admission

OnTheMarket plc (LON:OTMP), the agent-backed company which operates the OnTheMarket.com property portal, has today announced that as of 25 May it has signed listing agreements with UK estate and letting..

Advanced Oncotherapy Plc Successful testing supporting the superior clinical outcomes of LIGHT

Advanced Oncotherapy Plc (LON:AVO), the developer of next-generation proton therapy systems for cancer treatment, provided today the following technological update. The LIGHT system has been designed to electronically control the..

ImmuPharma PLC Further Phase III Lupuzor Trial Analysis Shows Positive Results in the Europe Cohort

ImmuPharma PLC (LON:IMM), the specialist drug discovery and development company, has today announced further analysis of the results from its pivotal Phase III trial of Lupuzor™, its lead programme for..

SkinBioTherapeutics Plc Involved in new research grant at University of Manchester

SkinBioTherapeutics plc (LON:SBTX), a life science company focused on skin health, announced today its collaboration as industrial partner in a grant awarded by the Biotechnology and Biological Sciences Research Council..

RedstoneConnect Plc Another year of continued progress across all our business units

RedstoneConnect Plc (LON:REDS), a leading provider of technology and services for smart buildings and commercial spaces, announced today its final results for the year ended 31 January 2018. Financial Highlights:..

Search

Funds

May 29, 2018

Search

Funds

May 29, 2018

FTSE 100

Funds